Systemic Antifungals
High-yield Verified · Jul 2026Prototype: fluconazole
Systemic Antifungals are a class of medications used to treat invasive/systemic fungal infections.
The systemic counterparts to the topical antifungals — for invasive fungal disease, with much more serious toxicity.
How it works in the body
The system involved, what goes wrong, and how the drug and body interact.
01 The target — the fungal membrane and wall
Fungal cells are protected by a membrane built around ergosterol (the fungal equivalent of the cholesterol in human membranes) and a cell wall made of glucan. Systemic antifungals attack these fungal-specific structures. Because human cells use cholesterol, not ergosterol, targeting ergosterol gives selectivity — but it isn’t perfect, which is why systemic antifungals are more toxic than antibiotics.
Three classes matter: azoles (fluconazole, voriconazole — the workhorses), polyenes (amphotericin B — the heavy hitter), and echinocandins (the `-fungin` drugs — the best tolerated).
02 Amphotericin B — effective but "ampho-terrible"
Amphotericin B is the broad, potent drug reserved for severe/life-threatening fungal infections — and it is notoriously toxic, nicknamed "ampho-terrible." Two toxicities dominate: infusion reactions (fever, chills/rigors, nausea — often premedicated with acetaminophen, antihistamine, ± meperidine for rigors) and nephrotoxicity with potassium and magnesium wasting (hypokalemia/hypomagnesemia). Slow infusion, hydration, electrolyte repletion, and lipid formulations (less nephrotoxic) reduce the harm.
The azoles are far better tolerated but are CYP450 inhibitors — a major source of drug interactions (raising levels of statins, warfarin, and many others) — and can be hepatotoxic and prolong the QT. Echinocandins (`-fungin`) are IV and the best tolerated, used especially for invasive Candida.
Drug names
Indications
- Invasive/systemic fungal infections (candidemia, aspergillosis, cryptococcal meningitis, endemic mycoses)
- Serious mucosal candidiasis; antifungal prophylaxis in immunocompromised patients
- Amphotericin B for severe/refractory disease; echinocandins for invasive Candida
Mechanism of action
Azoles inhibit ergosterol synthesis (CYP-dependent 14-α-demethylase), disrupting the fungal membrane. Amphotericin B binds ergosterol, forming membrane pores that leak cell contents. Echinocandins inhibit β-(1,3)-glucan synthase, weakening the cell wall.
Therapeutic effects — what you'll see working
Success is clearing an invasive fungal infection. The nursing focus is amphotericin’s infusion/renal toxicity and the azoles’ drug interactions and liver/QT effects.
- Fungicidal/fungistatic effect
- Disrupting the fungal membrane or wall clears invasive infection over the treatment course.
Adverse effects
The profile depends on the class: amphotericin (infusion + renal/electrolyte), azoles (interactions, liver, QT), echinocandins (well tolerated).
Interactions
Contraindications
The cautions are renal disease (amphotericin), the many azole interactions, and pregnancy/QT.
Labs & levels
Nursing considerations
The RN-specific layer — each action paired with the reason it matters.
Common questions
What are Systemic Antifungals used for?
How do Systemic Antifungals work?
What are the serious side effects of Systemic Antifungals?
What labs should be monitored with Systemic Antifungals?
See also
The original β-lactams — bactericidal cell-wall inhibitors. The defining nursing job is screening for and recognizing allergy, from rash to anaphylaxis.
β-lactam cousins of penicillin, organized by generation — each generation trades some gram-positive reach for broader gram-negative coverage.
Powerful, broad-spectrum DNA-synthesis blockers — but a boxed warning for disabling tendon, nerve, and CNS effects means they’re reserved when alternatives exist.
Suppress viral replication rather than kill viruses outright. The nursing essentials: hydrate with acyclovir, start early (flu within 48 h), and remember most antivirals suppress — they don’t cure.
Powerful IV drugs for serious Gram-negative infection — but nephrotoxic and ototoxic. Levels matter.
Broad, generally safe protein-synthesis inhibitors — a penicillin-allergy alternative. Watch QT and CYP3A4.
Sources
- Amphotericin B — nephrotoxicity, infusion reactions, electrolyte wasting — StatPearls (NCBI)
- Fluconazole / azole antifungals — ergosterol synthesis, CYP interactions — StatPearls (NCBI)
Reviewed by Hae Suk Lee, RN
Educational summary for nursing students. Always verify against current prescribing information and your institution's protocols before administering. Not medical advice.